3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Papillomavirus Infections
2
Breast Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Sexually Transmitted Diseases
1
Ovarian Cysts
1
Neoplasms
1
Menorrhagia
1
Lung Neoplasms
1
Leiomyoma
1
High-grade Anal Intraepithelial Neoplasia
1
HIV Infections
1
Endometriosis
1
Condylomata Acuminata
1
Benign Ovarian Tumor
1
Anus Neoplasms
1
Interventions
Fluorouracil
26
Radiotherapy
17
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Carboplatin
7
Magnetic Resonance Spectroscopy
6
Cetuximab
6
Biopsy
6
Papillomavirus Vaccines
5
Drug Therapy
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Observation
3
Light Coagulation
3
Ipilimumab
3
Interleukin-2
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anus Neoplasms
×
Electrocoagulation
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled